NEW YORK (GenomeWeb) – Exact Sciences has agreed to sell 7 million shares of its common stock at $35 per share in an underwritten public offering.

The company has also granted the underwriters an option to purchase nearly 1.1 million additional shares. If the over-allotment option is exercised, gross proceeds from the offering will be around $281.7 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.